SNTI Senti Biosciences Holdings, Inc.
Nasdaq · SEC CIK 1854270 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 57 since 2022-06-10, latest 2026-03-11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lu Timothy K | CEO, Dir | — | — |
| Rajangam Kanya | Pres, Chief Med, Dev. Off | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | SNTI | Lu Timothy K | CEO, Dir | F - Tax | $0.00 | -80.7K | 639.6K | -11% | $0 | |
| 2026-03-11 | 2026-03-09 | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | F - Tax | $0.00 | -10.8K | 74.8K | -13% | $0 | |
| 2026-02-03 | 2026-02-02 | SNTI | Lu Timothy K | CEO, Dir | F - Tax | $0.00 | -4,191 | 720.2K | -0.6% | $0 | |
| 2026-02-03 | 2026-02-02 | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | F - Tax | $0.00 | -1,384 | 85.6K | -2% | $0 | |
| D | 2025-03-14 | 2025-03-10 | SNTI | Celadon Partners SPV 24 | 10% | C - Cnv Deriv | — | +9.78M | 9.78M | New | — |
| D | 2025-03-12 | 2025-03-10 | SNTI | Florence Anthony A. Jr. | 10% | C - Cnv Deriv | — | +3.33M | 3.78M | +753% | — |
| D | 2025-03-12 | 2025-03-10 | SNTI | Bayer US Holding LP | 10% | C - Cnv Deriv | — | +2.22M | 2.81M | +378% | — |
| DI | 2025-03-11 | 2025-03-10 | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | C - Cnv Deriv | $2.25 | +33.0K | 33.0K | New | +$74.2K |
| D | 2025-03-10 | 2025-03-07 | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | A - Grant | $0.00 | +78.4K | 87.0K | +909% | $0 |
| D | 2025-03-10 | 2025-03-07 | SNTI | Lu Timothy K | CEO, Interim PFO, PAO, Dir | A - Grant | $0.00 | +642.4K | 724.4K | +783% | $0 |
| M | 2025-02-06 | 2025-02-04+ | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | S - Sale | $4.11 | -1,479 | 8,621 | -15% | -$6,074 |
| M | 2025-02-06 | 2025-02-04+ | SNTI | Lu Timothy K | CEO, Dir | S - Sale | $4.11 | -4,467 | 82.1K | -5% | -$18.3K |
| D | 2024-02-02 | 2024-02-01 | SNTI | Lu Timothy K | CEO, Pres, Dir | A - Grant | $0.00 | +306.0K | 865.5K | +55% | $0 |
| D | 2024-02-02 | 2024-02-01 | SNTI | KNOBELMAN DEBORAH | CFO, Head of Corp. Development | A - Grant | $0.00 | +101.0K | 131.0K | +337% | $0 |
| D | 2024-02-02 | 2024-02-01 | SNTI | Rajangam Kanya | Chief Medical, Devt. Off | A - Grant | $0.00 | +101.0K | 101.0K | New | $0 |
| D | 2022-10-04 | 2022-10-03 | SNTI | KNOBELMAN DEBORAH | CFO | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| DI | 2022-06-10 | 2022-06-08 | SNTI | Farokhzad Omid | Dir | M - OptEx | $0.00 | +5.75M | 6.47M | +804% | $0 |
| DI | 2022-06-10 | 2022-06-08 | SNTI | Farokhzad Omid | Dir | J - Other | $0.00 | -4.52M | 1.95M | -70% | $0 |
| DI | 2022-06-10 | 2022-06-08 | SNTI | Farokhzad Omid | Dir | A - Grant | $10.00 | +250.0K | 250.0K | New | +$2.50M |
| D | 2022-06-10 | 2022-06-08 | SNTI | Epstein David R | Dir | A - Grant | $0.00 | +112.5K | 123.3K | +1,048% | $0 |
| D | 2022-06-10 | 2022-06-08 | SNTI | Dynamics Sponsor LLC | Dir, 10% | M - OptEx | $0.00 | +5.75M | 6.47M | +804% | $0 |
| D | 2022-06-10 | 2022-06-08 | SNTI | Dynamics Sponsor LLC | Dir, 10% | J - Other | $0.00 | -6.47M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations